Clinical Trials in Houston

Showing 13141-13160 of 15,366 trials

Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

NCT00882258

Two (2) dose levels of Proellex or placebo will be administered once-daily for up to 91 days. Following screening and a pre-treatment endometrial biopsy, subjects will be followed monthly for the three month treatment phase.

Uterine Fibroids

Repros Therapeutics Inc.144 participantsStarted Mar 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +13 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

NCT00975143

The purpose of this study is to compare the efficacy and safety of CIP-Isotretinoin and a marketed (generic) formulation of isotretinoin when both are administered twice daily with meals.

Severe Nodular Acne

Cipher Pharmaceuticals Inc.925 participantsStarted Sep 2009

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • Fremont, California, United States +46 more locations

Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

Find Trials by Condition in Houston

Papillary Serous Carcinoma of the Endometrium

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Study of Donated Amnion, Fetal Placental Membrane, as Skin Substitute for Burn Patients

RAMP Study: A Study Comparing Two Lumbar Fusion Procedures

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium

Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes